Inhibrx Biosciences, Inc. INBX Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s common stock, shares issued (in shares)?
- Inhibrx Biosciences, Inc. (INBX) reported common stock, shares issued (in shares) of $14.61M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s common stock, shares issued (in shares) changed year-over-year?
- Inhibrx Biosciences, Inc.'s common stock, shares issued (in shares) increased by 0.9% year-over-year, from $14.48M to $14.61M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s common stock, shares issued (in shares)?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s common stock, shares issued (in shares) has grown at a -44.5% compound annual growth rate (CAGR), from $47.37M to $14.58M.